Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Sassone · SciRah

Researcher profile · Semantic Scholar

M. Sassone

Share profile

M. Sassone — researcher profile on SciRah

h-index: 13
Works: 50
Citations: 668

Most-cited papers

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era
A. Ferreri, Marta Bruno‐Ventre, G. Donadoni, M. Ponzoni +7 more
2015British Journal of Haematology113 citations
Semantic Scholar
MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
A. Ferreri, T. Calimeri, P. Lopedote, Ilaria Francaviglia +30 more
2021British Journal of Haematology84 citations Open access
Semantic Scholar
Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment.
M. Sassone, M. Ponzoni, A. Ferreri
2017Baillière's Best Practice & Research: Clinical Haematology56 citations
Semantic Scholar
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
C. Visco, L. Marcheselli, Roberto Mina, M. Sassone +53 more
2021Blood Advances54 citations Open access
Semantic Scholar
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
A. Ferreri, T. Calimeri, G. Conte, D. Cattaneo +17 more
2019Blood53 citations Open access
Semantic Scholar
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
A. Ferreri, M. Sassone, B. Kiesewetter, Silvia Govi +3 more
2015Annals of Oncology52 citations Open access
Semantic Scholar
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
A. Ferreri, M. Sassone, F. Zaja, A. Re +18 more
2017The Lancet Haematology35 citations Open access
Semantic Scholar
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.
A. Ferreri, T. Calimeri, M. Ponzoni, F. Curnis +20 more
2020Blood Advances31 citations Open access
Semantic Scholar
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
A. Conconi, A. Chiappella, A. Ferreri, A. Stathis +25 more
2024Blood Advances28 citations Open access
Semantic Scholar
Clarithromycin as a “repurposing drug” against MALT lymphoma
A. Ferreri, C. Cecchetti, B. Kiesewetter, M. Sassone +4 more
2018British Journal of Haematology21 citations Open access
Semantic Scholar
Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia.
S. Mariani, L. Tornaghi, M. Sassone, S. Basciani +4 more
2010Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis16 citations
Semantic Scholar
Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography
Benedetta Puccini, L. Nassi, C. Minoia, Stefano Volpetti +14 more
2017Annals of Hematology15 citations Open access
Semantic Scholar
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
A. Ferreri, M. Sassone, E. Miserocchi, S. Govi +11 more
2020Blood Advances13 citations Open access
Semantic Scholar
Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation
A. Ferreri, M. Sassone, P. Angelillo, F. Zaja +22 more
2020Hematological Oncology12 citations
Semantic Scholar
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients
Arianna Zappaterra, I. Civettini, A. Cafro, L. Pezzetti +15 more
2024Blood transfusion = Trasfusione del sangue11 citations
Semantic Scholar
A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
A. Ferreri, C. Cattaneo, A. Lleshi, L. Verga +14 more
2020British Journal of Haematology9 citations Open access
Semantic Scholar
Prophylaxis with high‐dose methotrexate significantly reduces CNS dissemination in patients with diffuse large B‐cell lymphoma (DLBCL) and high‐risk CNS‐IPI score
A. Ferreri, T. Calimeri, C. Cecchetti, A. Vignati +5 more
20178 citations Open access
Semantic Scholar
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma
A. Ferreri, P. Angelillo, F. Erbella, C. Cattaneo +14 more
2022Blood Advances7 citations Open access
Semantic Scholar
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma
M. Pirosa, M. Sassone, B. Kiesewetter, A. Guillermo +12 more
2022Haematologica6 citations Open access
Semantic Scholar
Antibiotic treatment for bacteria-associated extranodal marginal zone lymphoma
M. Sassone, M. Ponzoni, A. Ferreri
20216 citations Open access
Semantic Scholar
Autoimmune haemolytic anaemia in mantle cell lymphoma : an insidious complication associated with leukemic disease
E. Doni, G. Carli, A. Di Rocco, M. Sassone +5 more
2017Hematological Oncology6 citations Open access
Semantic Scholar
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants
S. Redaelli, R. Piazza, Roberta Rostagno, M. Sassone +5 more
20085 citations
Semantic Scholar
Mature, solid teratoma of the fallopian tube.
E. Alenghat, M. Sassone, A. Talerman
1982Journal of reproductive medicine5 citations
Semantic Scholar
Risk-Tailored CNS Prophylaxis In 194 Patients With Diffuse Large B-CELL Lymphoma (DLBCL) Treated In The Rituximab ERA: Risk Definition By Clinical Variables and Ontogenic Stratification
M. Ventre, M. Foppoli, G. Citterio, G. Donadoni +5 more
20134 citations
Semantic Scholar
Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
S. Steffanoni, T. Calimeri, A. Laurenge, C. Fox +24 more
2022British Journal of Haematology3 citations Open access
Semantic Scholar
High-dose methotrexate (HD-MTX) as CNS prophylaxis significantly improves outcome in patients with high-risk diffuse large B-cell lymphoma (DLBCL)
T. Calimeri, C. Cecchetti, A. Vignati, M. Sassone +4 more
20163 citations Open access
Semantic Scholar
Six-Month Doxycycline Is Safe and Effective As Upfront Monotherapy for Stage-I Malt Lymphoma of the Ocular Adnexae: Primary Endpoint Results of the IELSG39 Trial
A. Ferreri, M. Sassone, M. Cangi, G. Magliacane +17 more
2022Blood2 citations Open access
Semantic Scholar
CLARITHROMYCIN AS a “REPURPOSING DRUG” AGAINST LYMPHOMAS: SAFETY AND EFFICACY PROFILES IN 55 PATIENTS WITH EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL)
A. Ferreri, C. Cecchetti, B. Kiesewetter, M. Sassone +4 more
20172 citations Open access
Semantic Scholar
Lenalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) in Patients with Chemosensitive Relapse of Diffuse Large B-Cell Lymphoma (DLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT) or Experienced Relapse after Transplantation: Results of a Multicentre
A. Ferreri, M. Sassone, Marianna Chiozzotto, M. Spina +13 more
20152 citations
Semantic Scholar
Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication
E. Flospergher, M. Sassone, A. Chiara, F. Marino +11 more
2025Advances in Radiation Oncology1 citations Open access
Semantic Scholar
SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHOMA: PRESENTATION, EFFECTS ON TUMOR TREATMENT AND OUTCOME IN A SERIES OF THE INTERNATIONAL PCNSL COLLABORATIVE GROUP
A. Ferreri, S. Steffanoni, T. Calimeri, A. Laurenge +14 more
2021Hematological Oncology1 citations
Semantic Scholar
SAFETY AND EFFICACY OF THE “CARMEN” REGIMEN, A NEW DOSE‐DENSE SHORT‐TERM THERAPY IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA AND MYC REARRANGEMENT
A. Ferreri, P. Angelillo, F. Erbella, C. Liberatore +14 more
2021Hematological Oncology1 citations Open access
Semantic Scholar
Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma
A. Ferreri, T. Calimeri, M. Ponzoni, F. Curnis +20 more
2020Social Science Research Network1 citations
Semantic Scholar
R‐CHOP PRECEDED BY ENGINEERED TUMOR NECROSIS FACTOR (TNF) IN RELAPSED OR REFRACTORY PRIMARY DIFFUSE LARGE B‐CELL LYMPHOMA OF THE CNS (rPCNSL): FINAL RESULTS OF THE INGRID TRIAL
A. Ferreri, T. Calimeri, G. Conte, M. Ponzoni +18 more
2019Hematological Oncology1 citations
Semantic Scholar
Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
A. Ferreri, T. Calimeri, P. Lopedote, Ilaria Francaviglia +24 more
2019Blood1 citations Open access
Semantic Scholar
Lenalidomide Maintenance Significantly Improves Survival Figures in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Final Results of a Multicentre Phase II Trial
A. Ferreri, M. Sassone, F. Zaja, A. Re +19 more
20161 citations
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
A. Ferreri, M. Sassone, M. Cangi, G. Magliacane +18 more
2023Hematological Oncology0 citations Open access
Semantic Scholar
Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
T. Calimeri, S. Steffanoni, A. Laurenge, C. Fox +24 more
2022Blood0 citations Open access
Semantic Scholar
Antiemetic Prophylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to Prevent Chemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin'S Lymphoma Naïve Patients Receiving ABVD Regimen: A Multicenter Phase Iia Study
D. Nasso, S. Bolis, E. Abruzzese, Ilaria Romano +11 more
20200 citations Open access
Semantic Scholar
Hematoma-like primary cutaneous peripheral T-cell lymphoma: a rare clinical presentation.
S. Mercuri, G. Paolino, L. Colombo, P. Bearzi +5 more
2020Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia0 citations Open access
Semantic Scholar
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT)
A. Ferreri, M. Sassone, P. Angelillo, F. Zaja +17 more
2019Hematological Oncology0 citations
Semantic Scholar
INTRALESIONAL RITUXIMAB SUPPLEMENTED WITH AUTOLOGOUS SERUM IN RELAPSED CD20+ INDOLENT LYMPHOMAS OF THE CONJUNCTIVA: ACTIVITY AND SAFETY RESULTS OF THE “IRIS” TRIAL
A. Ferreri, M. Sassone, E. Miserocchi, Silvia Govi +7 more
2019Hematological Oncology0 citations
Semantic Scholar
R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial
A. Ferreri, T. Calimeri, G. Conte, D. Cattaneo +20 more
2018Blood0 citations
Semantic Scholar
R-CHOP preceded by blood-brain barrier permeabilization (BBBp) by NGR-tumor necrosis factor (NGR-hTNF) in patients with relapsed or refractory primary CNS lymphoma (rrPCNSL): First results of the “INGRID” phase II trial.
A. Ferreri, T. Calimeri, G. Conte, P. Lopedote +15 more
20180 citations
Semantic Scholar
Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years
A. Ferreri, M. Sassone, F. Zaja, A. Re +18 more
2018Blood0 citations Open access
Semantic Scholar
1022PSafety and tolerability of chemotherapy (CT) containing high doses of methotrexate (HD-MTX) and cytarabine (Ara-C) in patients with primary central nervous system lymphoma (PCNSL) and hepatitis B virus (HBV) infection
T. Calimeri, P. Lopedote, M. Repetto, A. Vignati +10 more
20170 citations Open access
Semantic Scholar
1003PDA multicentre phase II trial addressing lenalidomide (LEN) maintenance in patients with relapsed diffuse large b-cell lymphoma (rDLBCL) who are not eligible for autologous stem cell transplantation (ASCT)
M. Sassone, F. Zaja, A. Re, M. Spina +12 more
20170 citations Open access
Semantic Scholar
Safety and efficacy of clarithromycin monotherapy in patients (pts) with extranodal marginal zone lymphoma (EMZL)
C. Cecchetti, B. Kiesewetter, M. Sassone, T. Calimeri +3 more
20160 citations Open access
Semantic Scholar
A Pathologic Abdominal Ultrasonography At Diagnosis Of CLL Significantly Reduces The Time To Progression In Patients With Rai 0 Or Rai 1 Disease
F. Rossini, C. Cecchetti, F. Farina, M. Sassone +7 more
20130 citations
Semantic Scholar
Interim (18)F-FDG PET prognostic value in Hodgkin lymphoma patients
M. Kirienko, L. Guerra, S. Bolis, M. Sassone +2 more
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ponzoni×27
Invite
M. Ponzoni — researcher profile on SciRah
T. Calimeri×27
Invite
T. Calimeri — researcher profile on SciRah
A. Ferreri×21
Invite
A. Ferreri — researcher profile on SciRah
C. Cecchetti×19
Invite
C. Cecchetti — researcher profile on SciRah

×16

Invite

M. Foppoli — researcher profile on SciRah

Invite

S. Perrone — researcher profile on SciRah

Invite

A. Ferreri — researcher profile on SciRah

P. Angelillo×10

Invite

P. Angelillo — researcher profile on SciRah

Invite

F. Ciceri — researcher profile on SciRah

Invite

M. Spina — researcher profile on SciRah

Invite

L. Scarfò — researcher profile on SciRah

Invite

F. Zaja — researcher profile on SciRah